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Genotypes and Antibiotic Resistances of Campylobacter jejuni and
Campylobacter coli Isolates from Domestic and Travel-Associated
Human Cases
Lilian Niederer,a Peter Kuhnert,a Ralph Egger,a Sabina Büttner,b Herbert Hächler,c and Boz˙ena M. Korczaka
Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerlanda; Swiss Federal Veterinary Office, Bern, Switzerlandb; and Swiss National Centre
for Enteropathogenic Bacteria (NENT), Institute for Food Safety and Hygiene, University of Zurich, Zurich, Switzerlandc
Multilocus sequence typing (MLST) extended with flaB typing of 425 Campylobacter jejuni isolates and 42 Campylobacter coli
isolates revealed quite a low overlap between human isolates from travel-associated and domestic cases in Switzerland. Men were
more frequently affected by Campylobacter than women, but strains fromwomen and, overall, from travel-associated cases
showedmutations conferring quinolone resistance more frequently than strains frommen and domestic cases, respectively.
Campylobacter jejuni and Campylobacter coli are the majorcauses of bacterial gastroenteritis worldwide. In Switzerland,
the reported incidence is one of the highest in Europe (3, 4, 9, 21,
23). The infection occurs mainly after the handling of raw meat
and the consumption of undercooked contaminated meat, but
traveling abroad has also been recognized as a risk factor (9, 20–
22). To gain information on genotypes and antibiotic resistances
of strains implicated in either domestic or travel-associated cases,
425 C. jejuni isolates and 42 C. coli isolates representing 8.2% of all
reported cases in the sampling period from June to December
2009 in Switzerland were investigated (Table 1). Most of the iso-
lates (383; 82.0%) were obtained from domestic cases. Taking into
consideration the incubation time of Campylobacter spp. and how
long clinical symptoms last, the remaining 84 isolates (18.0%)
from patients who had been abroad within the last 2 weeks prior to
medical consultation were classified as travel associated (4). This is
quite a low rate in comparison to that of an earlier case-control
study conducted in Switzerland, where 46.1% of investigated cases
were associated with foreign travel (22). The distribution of iso-
lates within the particular age groups of patients was highly re-
flected in the proportion calculated for all reported cases in Swit-
zerland in 2009 (http://www.bag.admin.ch), underlining the
representativeness of the spot sample.
A significantly higher number of patients were male (267;
57.2%), as found in other studies (11, 12, 21). The reason for this
dimorphism in campylobacteriosis is yet unknown, but it has been
speculated that there are sexual differences concerning handling
and consumption of meat (21). However, Strachan et al. (25) chal-
lenged this view by showing similar differences in rates of campy-
lobacteriosis even in children younger than 1 year old, in whom
behaviors are expected to be similar regardless of gender. More-
over, these authors observed similarly different predispositions
toward campylobacteriosis based on gender when male and fe-
male mice were infected with C. jejuni.
In terms of age (Table 1), patients in the travel group were
significantly younger (median, 30 years) than those of the domes-
tic group (median, 38 years) (P 0.021).
The distribution of species (91.0% C. jejuni and 9.0% C. coli)
reflected the proportion found in other studies from various
countries and confirms C. jejuni as the main causative agent of
campylobacteriosis (11, 23). There was no association between
Campylobacter species and age, gender, or travel history. This con-
trasts with an English study which described a dependence be-
tween C. coli and female and older patients (11).
Multilocus sequence typing (MLST), flaB typing, and genetic
determination of resistance to quinolones and macrolides, the two
main groups of antibiotics used for treatment of severe cases,
based on the sequencing of gyrA and 23S rRNA gene fragments,
respectively, were performed as described previously (2, 5, 6, 17,
19). In contrast to the previously described protocol (17), 5
FIREPol master mix ready to load (Solis BioDyne, Tartu, Estonia)
was used. This led to the following composition for each 30.0-l
multiplex PCR: 0.4 M appropriate primer, 1 FIREPol master
mix ready to load, 1.0 l lysate (approximately 30 ng DNA), and
the addition of MgCl2 up to a final concentration of 5 mM. Data
analysis was performed as previously described by Kittl et al. (16).
MLST resulted in 111 sequence types (STs), and flaB typing
resulted in 87 types; 17 of each were new (Table 2). The C. jejuni
isolates showed much higher diversity than the C. coli isolates, as
indicated by the distribution of the strains within different clonal
complexes (CCs). Of the investigated C. coli strains, 95.0% could
be assigned to CC828, confirming a higher clonality within this
species (17, 24, 26).
Despite the many CCs within the C. jejuni strains, the majority
of strains (62.0%) could be assigned to the three most common
CCs, i.e., CC21, CC48, and CC257. These lineages were frequently
found in human samples described in other studies from different
countries (6, 18, 23). This suggests that they might be the best
adapted or most pathogenic for humans. Interestingly, as previ-
ously described (16), less than 2.0% of C. jejuni isolates belonged
to CC45, which is the most common CC found in humans in most
countries and especially in Finland (15, 23). As poultry is sup-
posed to be the main source of campylobacteriosis, the number of
human isolates belonging to CC45 is remarkably low even though
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it was one of the most frequent CCs found in Swiss broilers (28).
There is no obvious explanation for this, and further investigation
is needed.
As with previous investigations,flaB typing was poorly congru-
ent with MLST (17, 28). Thus, a combination of MLST and flaB
typing increased discrimination, as reflected in a higher Simpson’s
index of diversity: 0.970 compared to 0.928 for MLST and 0.921
for flaB typing alone. This provided appropriate information for
the study of Campylobacter epidemiology.
Only 25 out of 65 combined MLST-flaB genotypes, found in
the group of travel-associated cases and represented by 51.2% of
isolates, matched those of the isolates obtained from domestic
cases. The existing overlap of these two groups was due mainly to
ST-21, ST-50, and ST-48 combined with flaB type 103, which were
represented in both of them and which are the most frequent STs
worldwide (15, 16, 18). Conversely, the new STs found among
2.6% of domestic strains, together with ST-3963, which was first
described in isolates from Swiss broilers in 2008 and which also
appeared among the domestic isolates, might represent clones
that are endemic to Switzerland. The difference in population
structures of the two groups of isolates was confirmed by a low
proportional similarity index (PSI, 0.35) (10).
A significantly higher number of quinolone-resistant strains
was found among travel-associated cases (56.0%) than among
domestic cases (39.4%) (Table 2). Foreign travel as a risk factor for
infection with quinolone-resistant Campylobacter species strains
had been described previously, but the reason for this remains
unknown (14). The rates of quinolone-resistant strains in humans
in different countries range from 0% to over 80%, and this varia-
tion could be ascribed to the divergent use of quinolones in food-
producing animals (8). A correlation between licensing quinolone
use in food animals and the appearance of resistant strains in
humans has been shown previously (1).
There was no significant difference in the rates of quinolone
resistance between strains of domestic origin and those from pa-
tients who have traveled to member countries of the European
Union. This could be due to similar regulations in Switzerland and
European Union member countries, because both ban the use of
antibiotics as feed additives (8). In contrast, a considerably higher
rate of quinolone resistance was observed in strains acquired in
Asia, consistent with previous reports (7, 14). In addition, travel-
ers to Asia and Latin America often take preventive antibiotics,
such as quinolones (7).
A high number of resistant strains in the group of travel-
associated cases belonged to STs which did not occur in the
group of domestic cases. Strains with the common STs found in
both groups showed no significant difference in antibiotic re-
sistance.
Most strains resistant to quinolones (88.4%) possessed the
C257T transition in the gyrA gene (Table 3); this is the most fre-
quent mutation in C. jejuni and C. coli (2). Interestingly, we found
a strong association between the double mutation C257T C310A
and the domestic isolates representing ST-50 and flaB type 103,
data in support of a clone endemic to Switzerland. At position 310,
a substitution of serine (TCA) for proline (CCA), conferring re-
sistance to quinolones, is normally observed (2). The effect on
resistance of the transversion from CCA (proline) to ACA (thre-
onine) found in our strains could not be tested because of the
presence of the C257T mutation, which singly confers quinolone
resistance.
The only isolate resistant to macrolides was also phenotypically
resistant to quinolones. Remarkably, it possessed a novel double
mutation within the gyrA triplet coding for Thr86 that led to
Thr86Val (GenBank accession no. JN815082). This strain was iso-
lated from a patient who had traveled to Bali, and it had probably
undergone different selection pressures than the other isolates.
The analysis of quinolone resistance with respect to gender
revealed a significantly higher percentage in women (48.7%) than
in men (38.4%) (P  0.029), a finding, to our knowledge, not
described before. There might be a connection with urinary tract
infections, which are more frequently diagnosed in women than
in men and, in many cases, treated with quinolones (13). This
might lead to the secondary acquisition of posttherapeutic resis-
tance to this class of antibiotics in Campylobacter. In contrast to
another study which described higher rates of quinolone resis-
tance in C. coli (27), we found no significant difference in antibi-
otic resistance rates between C. jejuni and C. coli.
In conclusion, there are differences between Swiss domestic
and travel-associated Campylobacter isolates with respect to geno-
type and quinolone resistance.
TABLE 1 Number of isolates according to age and gender of patientsa
Patient age
(yr)
No. of isolates
Total no. of
isolates
Female Male
Domestic case
Travel-associated
case Domestic case
Travel-associated
case
0–9 13 (6) 2 (1) 16 (2) 7 (3) 38 (12)
10–19 17 (6) 5 (2) 18 (5) 5 (4) 45 (17)
20–29 39 (24) 11 (9) 48 (16) 10 (5) 108 (54)
30–39 27 (12) 6 (4) 26 (9) 13 (6) 72 (31)
40–49 23 (11) 3 (1) 40 (18) 5 (2) 71 (32)
50–59 14 (7) 1 (1) 24 (10) 9 (5) 48 (23)
60–69 14 (5) 1 (0) 26 (9) 4 (3) 45 (17)
70–79 14 (6) 2 (1) 10 (2) 0 (0) 26 (9)
80 6 (0) 0 (0) 4 (2) 0 (0) 10 (2)
Unknown 2 (1) 0 (0) 2 (0) 0 (0) 4 (1)
Total 169 (78) 31 (19) 214 (73) 53 (28) 467 (198)
a Numbers of quinolone-resistant isolates are in parentheses.
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TABLE 2 Distribution of CCs, STs, and flaB types among C. jejuni and C. coli strains isolated from humans in 2009a
Species CC ST flaB type
No. of
domestic cases
No. of travel-
associated cases Species CC ST flaB type No. of domestic cases
No. of travel-
associated cases
C. jejuni 21 8 1525 1 (0) 4370 103 1 (1)
19 36 7 (6) 4370 1535 1 (1)
19 53 2 (0) 5108 1530 1 (1)
21 8 1 (1) 354 354 18 1 (1)
21 51 1 (0) 354 222 1 (0)
21 103 32 (11) 8 (2) 878 34 4 (3)
21 105 1 (0) 1073 208 5 (1) 1 (0)
21 198 35 (20) 4 (3) 5098 34 2 (2)
21 226 3 (0) 5105 18 1 (1)
21 371 1 (0) 403 403 51 1 (0)
21 414 9 (0) 1775 51 1 (0)
21 487 1 (1) 443 51 21 8 (6) 1 (1)
21 1520 1 (0) 446 446 222 1 (1) 1 (1)
21 1526 1 (0) 862 222 1 (0)
21 1529 1 (1) 2850 18 1 (1)
50 36 16 (1) 4 (1) 460 989 34 1 (1)
50 103 20 (20) 1 (0) 4701 34 1 (0)
50 350 3 (0) 5106 34 1 (1)
50 431 2 (2) 574 2031 112 1 (1)
50 1246 1 (1) 1 (1) 4057 402 1 (1)
262 137 11 (0) 1 (0) 607 607 14 1 (1)
883 103 1 (0) 3963 103 6 (0)
883 1386 1 (1) 3963 1519 1 (0)
917 96 2 (0) 658 657 5 2 (1)
1519 34 1 (1) 1044 5 1 (1)
1943 138 1 (1) 1900 117 1 (0) 1 (1)
2135 260 1 (1) 677 677 864 5 (0)
3102 34 2 (2) 1034 1709 18 1 (0)
5104 198 2 (2) 1709 1528 1 (0)
5107 103 1 (1) ND 441 34 4 (4)
22 22 309 1 (0) 441 198 1 (1)
22 442 5 (1) 1 (0) 448 1514 1 (0)
22 1516 1 (0) 449 612 1 (1)
5103 442 1 (0) 464 34 1 (1)
42 42 177 1 (0) 1 (0) 464 45 3 (3)
45 45 15 1 (0) 464 103 2 (2)
45 21 1 (0) 464 1522 1 (1)
45 31 1 (0) 464 1533 2 (2)
45 307 1 (0) 531 100 1 (1)
137 16 1 (0) 586 402 2 (0)
418 307 1 (0) 881 67 1 (1) 1 (1)
583 177 1 (1) 1367 1513 2 (0)
755 22 1 (0) 1726 402 1 (1)
1964 31 1 (0) 2175 350 1 (0)
48 48 36 1 (0) 2274 112 1 (1)
48 103 32 (4) 3 (1) 2274 117 1 (1)
48 105 1 (0) 2274 1248 1 (1) 1 (1)
48 198 1 (0) 2332 54 1 (1)
475 105 1 (0) 1 (0) 3544 49 1 (1)
2309 103 1 (1) 4373 208 1 (1)
5109 103 1 (0) 4800 67 1 (1)
49 49 11 1 (0) 5100 16 1 (1b)
52 52 57 2 (1) 3 (2) 5101 1518 1 (0)
5110 57 1 (0) 5102 260 1 (1)
61 61 44 1 (0) Total 351 (139) 74 (40)
61 1179 3 (0) C. coli 828 825 16 3 (2)
61 1209 1 (0) 827 66 1 (0)
206 122 47 4 (0) 827 103 1 (0)
122 395 3 (1) 1 (1) 827 236 14 (4) 1 (0)
227 47 1 (1) 1 (1) 827 556 1 (1)
572 47 2 (2) 854 915 1 (0)
572 105 1 (0) 855 66 1 (0)
572 198 1 (1) 1 (1) 872 16 1 (0)
572 1384 1 (1) 872 30 1 (1)
3335 96 1 (1) 899 13 1 (1)
5099 986 1 (1) 1145 494 1 (1)
257 257 16 19 (1) 2 (1) 1173 765 2 (2)
257 301 13 (3) 1 (1) 1191 16 1 (0)
367 16 1 (1) 1413 1524 1 (0)
824 34 1 (1) 1 (0) 2142 66 1 (0) 1 (1)
2254 16 1 (1) 2273 1117 1 (0)
283 267 177 1 (0) 3336 1517 1 (0)
383 177 3 (0) 3990 30 1 (1)
353 5 96 3 (3) 5111 17 1 (1)
353 45 3 (0) 1 (1) 5112 125 1 (0)
356 114 1 (0) 5113 13 1 (1)
400 67 1 (0) 5114 1532 1 (1)
2801 320 1 (1) ND 1143 824 1 (1)
2849 96 2 (2) 1592 836 1 (1)
2882 96 1 (1) Total 32 (12) 10 (7)
4370 67 2 (2)
a The numbers of quinolone-resistant isolates are in parentheses. New STs and/or new flaB types are in bold. ND, not defined.
b Strain resistant to quinolone and macrolide.
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